Ticker ADPT – Adaptive Biotechnologies – sales, description, marketcap – Tickerday.com

ADPT

Adaptive Biotechnologies

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 5.34B; Volume: 1.34M; AvgVol 3m: 1.06M; Beta: –;

Cost estimate:

P/E: –; EPS: -0.79; EPS growth quarter/prev quarter: -90.50%;

EPS growth this year: -42.00%; EPS growth past 5 years: ;

EPS ttm: -0.79;

P/S: 73.62; P/B: 11.74; P/Cashflow: 11.90; P/FCF: ;

Sales: 92.17M; Sales growth quarter/prev quarter: -5.00%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 76.30%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -11.20%; ROE – return on equity: -17.80%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.40%; Insider Transactions:-66.66%;

Institutional Ownership: 74.60%; Institutional Transactions: 3.98%;

Data update: 07.10.2020.